Co-Authors
This is a "connection" page, showing publications co-authored by CHRIS AMOS and ROBERT RIPLEY.
Connection Strength
0.528
-
Methylation signatures distinguish non-small cell lung cancer subtypes and are associated with survival in smokers with lung squamous cell carcinoma. J Natl Cancer Inst. 2026 Jul 01; 118(7):1299-1312.
Score: 0.246
-
Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre-cancer lesions. Int J Cancer. 2025 Dec 16.
Score: 0.059
-
GASPS: A Multi-Omics Framework for Defining Genomic Aberration-Driven Signatures and Predicting Patient Outcomes in Lung Cancer. bioRxiv. 2025 Aug 25.
Score: 0.058
-
Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre-cancer lesions. bioRxiv. 2025 Jul 30.
Score: 0.058
-
Cytotoxic and regulatory T cell interactions calculated from image mass cytometry predict immunochemotherapy response in triple-negative breast cancer. Cancer Commun (Lond). 2025 Apr; 45(4):392-396.
Score: 0.055
-
Clonal gene signatures predict prognosis in mesothelioma and lung adenocarcinoma. NPJ Precis Oncol. 2024 Feb 23; 8(1):47.
Score: 0.052